Performance Status as a Prognostic Factor in Japanese Patients With Myeloperoxidase–Antineutrophil Cytoplasmic Antibody–Positive Microscopic Polyangiitis
Tokio Katakura, Ken‐ei Sada, Masayoshi Harigai, Yuki Nakamura, Shouichi Fujimoto, Yukio Yuzawa et al. Performance Status as a Prognostic Factor in Japanese Patients With Myeloperoxidase–Antineutrophil Cytoplasmic Antibody–Positive Microscopic Polyangiitis. // ACR Open Rheumatology. – 2026. – DOI: 10.1002/acr2.90172. – URL: https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr2.90172?af=R
Tokio Katakura, Ken‐ei Sada, Masayoshi Harigai, Yuki Nakamura, Shouichi Fujimoto, Yukio Yuzawa, Kunihiro Yamagata, Masaki Kobayashi, Tatsuya Atsumi, Takahiko Sugihara, Naoto Tamura, Yoshihiro Arimura, Hirofumi Makino, & Izaya Nakaya (2026). Performance Status as a Prognostic Factor in Japanese Patients With Myeloperoxidase–Antineutrophil Cytoplasmic Antibody–Positive Microscopic Polyangiitis. ACR Open Rheumatology. https://doi.org/10.1002/acr2.90172
Tokio Katakura, et al. “Performance Status as a Prognostic Factor in Japanese Patients With Myeloperoxidase–Antineutrophil Cytoplasmic Antibody–Positive Microscopic Polyangiitis.” ACR Open Rheumatology, 2026. doi:10.1002/acr2.90172.
@article{Katakura2026,
title = {Performance Status as a Prognostic Factor in Japanese Patients With Myeloperoxidase–Antineutrophil Cytoplasmic Antibody–Positive Microscopic Polyangiitis},
author = {Katakura, Tokio and Sada, Ken‐ei and Harigai, Masayoshi and Nakamura, Yuki and Fujimoto, Shouichi and Yuzawa, Yukio and Yamagata, Kunihiro and Kobayashi, Masaki and Atsumi, Tatsuya and Sugihara, Takahiko and Tamura, Naoto and Arimura, Yoshihiro and Makino, Hirofumi and Nakaya, Izaya},
journal = {ACR Open Rheumatology},
year = {2026},
doi = {10.1002/acr2.90172},
url = {https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr2.90172?af=R}
}
Objective Black patients with systemic sclerosis (scleroderma) have more severe disease than White patients. We investigated whether racial differences in therapeutic responses to mycophenolate mofetil (MMF) could explain this...